instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Circulatory collapse'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the outcome of reaction 'Coma'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Not recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the outcome of reaction 'Haemorrhage intracranial'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Recovered | ReactionOutcome | CC BY | 33407142 | 18,822,543 | 2021-01-06 |
What was the outcome of reaction 'Hypoxic-ischaemic encephalopathy'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Not recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the outcome of reaction 'Ventricular fibrillation'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiocentric lymphoma'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enteritis'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, AZATHIOPRINE | DrugsGivenReaction | CC BY | 33407170 | 19,233,908 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemophagocytic lymphohistiocytosis'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | ADALIMUMAB, ASPARAGINASE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DOXORUBICIN, ETOPOSIDE, MESALAMINE, METHYLPREDNISOLONE, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
What was the administration route of drug 'ADALIMUMAB'? | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | Subcutaneous | DrugAdministrationRoute | CC BY | 33407170 | 19,233,908 | 2021-01-06 |
What was the dosage of drug 'AZATHIOPRINE'? | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | 100 mg (milligrams). | DrugDosage | CC BY | 33407170 | 19,233,908 | 2021-01-06 |
What was the outcome of reaction 'Condition aggravated'? | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | Fatal | ReactionOutcome | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
What was the outcome of reaction 'Haemophagocytic lymphohistiocytosis'? | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | Fatal | ReactionOutcome | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
BACKGROUND
Chronic active Epstein-Barr virus infection (CAEBV) is defined as Epstein-Barr virus (EBV)-positive T/NK cell-related neoplasia, and its major clinical symptom is systemic in... | Fatal | ReactionOutcome | CC BY | 33407170 | 19,246,748 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | MEROPENEM, VANCOMYCIN | DrugsGivenReaction | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
What was the administration route of drug 'MEROPENEM'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
What was the administration route of drug 'NOREPINEPHRINE'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407192 | 19,512,215 | 2021-01-06 |
What was the administration route of drug 'VANCOMYCIN'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
What was the dosage of drug 'MANNITOL'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | UNK, (MAXIMAL DOSE) | DrugDosageText | CC BY | 33407192 | 19,512,215 | 2021-01-06 |
What was the outcome of reaction 'Cardiac arrest'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Fatal | ReactionOutcome | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
What was the outcome of reaction 'Drug ineffective'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Fatal | ReactionOutcome | CC BY | 33407192 | 19,493,037 | 2021-01-06 |
What was the outcome of reaction 'Treatment failure'? | Klebsiella pneumoniae-related invasive liver abscess syndrome complicated by purulent meningitis: a review of the literature and description of three cases.
BACKGROUND
Klebsiella pneumoniae (K. pneumoniae) invasive liver abscess syndrome (ILAS) with purulent meningitis was rarely identified the mainland of China. Last ... | Fatal | ReactionOutcome | CC BY | 33407192 | 19,395,094 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | CARBOPLATIN, IRINOTECAN, SUNITINIB | DrugsGivenReaction | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | CARBOPLATIN, IRINOTECAN, SUNITINIB | DrugsGivenReaction | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | CARBOPLATIN, IRINOTECAN, SUNITINIB | DrugsGivenReaction | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Taste disorder'. | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | CARBOPLATIN, IRINOTECAN, SUNITINIB | DrugsGivenReaction | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
What was the dosage of drug 'CARBOPLATIN'? | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | 2 COURSES | DrugDosageText | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
What was the dosage of drug 'IRINOTECAN'? | Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.
BACKGROUND
Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of or... | 2 COURSES | DrugDosageText | CC BY | 33407304 | 19,263,369 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | FLUOROURACIL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, LEUCOVORIN, OLAPARIB, OXALIPLATIN | DrugsGivenReaction | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
What was the dosage of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | 40 MG TWICE PER DAY FROM DAY 1 TODAY 14 | DrugDosageText | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
What was the dosage of drug 'OLAPARIB'? | A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report.
In addition to ovarian and breast cancers, loss-of-function mutations in BRCA1 and BRCA2 genes are also linked to an increased risk of pancreatic cancer, with ~ 4 to 7% of pancreatic cancer patients harboring germline BRCA mu... | 150 mg (milligrams). | DrugDosage | CC BY | 33407459 | 19,274,581 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | CYCLOSPORINE, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 33407602 | 18,840,448 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | CYCLOSPORINE, METHYLPREDNISOLONE SODIUM SUCCINATE | DrugsGivenReaction | CC BY | 33407602 | 18,840,448 | 2021-01-06 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407602 | 18,785,322 | 2021-01-06 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407602 | 18,840,448 | 2021-01-06 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | Recovered | ReactionOutcome | CC BY | 33407602 | 18,840,448 | 2021-01-06 |
What was the outcome of reaction 'Pyrexia'? | Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
BACKGROUND
To summarize the characteristics of gastrointestinal (GI) perforation in anti-nuclear matrix protein 2 (NXP2) antibody-associated juvenile dermatomyositis (JDM).
METHODS
Five... | Recovered | ReactionOutcome | CC BY | 33407602 | 18,840,448 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthritis'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Butterfly rash'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lupus nephritis'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory syncytial virus infection'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | AZATHIOPRINE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the administration route of drug 'PREDNISONE'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Oral | DrugAdministrationRoute | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | 5 MILLIGRAM/KILOGRAM (5 MG/KG/D) | DrugDosageText | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | UNK (3 DAY PULSE) | DrugDosageText | CC BY | 33407629 | 18,908,879 | 2021-01-06 |
What was the outcome of reaction 'Arthritis'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the outcome of reaction 'Butterfly rash'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the outcome of reaction 'Disease recurrence'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the outcome of reaction 'Lupus nephritis'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the outcome of reaction 'Pneumonia'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
What was the outcome of reaction 'Respiratory syncytial virus infection'? | Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
BACKGROUND
Shrinking lung syndrome (SLS), a rare complication of systemic lupus erythematosus (SLE) characterized by dyspnea, low lung volumes, and a restrictive pattern on pulmonary fun... | Recovered | ReactionOutcome | CC BY | 33407629 | 18,886,056 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Antinuclear antibody positive'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular hypertrophy'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung infiltration'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Microscopic polyangiitis'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial effusion'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
What was the administration route of drug 'AZITHROMYCIN'? | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
What was the administration route of drug 'CEFTRIAXONE'? | ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure.
BACKGROUND
Microscopic polyangiitis (MPA) is a subtype of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), involving small and medium sized vessels, often affecting the kidneys and lungs. A... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33407881 | 19,165,871 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asphyxia'. | Determination of Seven Antidepressants in Pericardial Fluid by Means of Dispersive Liquid-Liquid Microextraction (DLLME) and Gas Chromatography-Mass Spectrometry (GC/MS).
Although blood is often used to detect and quantify the presence of drugs, there are some instances where samples obtained from other biological matr... | BENZODIAZEPINE, FLUOXETINE HYDROCHLORIDE, MIRTAZAPINE, PALIPERIDONE, QUETIAPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33410888 | 18,752,851 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choking'. | Determination of Seven Antidepressants in Pericardial Fluid by Means of Dispersive Liquid-Liquid Microextraction (DLLME) and Gas Chromatography-Mass Spectrometry (GC/MS).
Although blood is often used to detect and quantify the presence of drugs, there are some instances where samples obtained from other biological matr... | BENZODIAZEPINE, FLUOXETINE HYDROCHLORIDE, MIRTAZAPINE, PALIPERIDONE, QUETIAPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33410888 | 18,752,851 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Determination of Seven Antidepressants in Pericardial Fluid by Means of Dispersive Liquid-Liquid Microextraction (DLLME) and Gas Chromatography-Mass Spectrometry (GC/MS).
Although blood is often used to detect and quantify the presence of drugs, there are some instances where samples obtained from other biological matr... | BENZODIAZEPINE, FLUOXETINE HYDROCHLORIDE, MIRTAZAPINE, PALIPERIDONE, QUETIAPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33410888 | 18,752,851 | 2021-01-07 |
What was the outcome of reaction 'Asphyxia'? | Determination of Seven Antidepressants in Pericardial Fluid by Means of Dispersive Liquid-Liquid Microextraction (DLLME) and Gas Chromatography-Mass Spectrometry (GC/MS).
Although blood is often used to detect and quantify the presence of drugs, there are some instances where samples obtained from other biological matr... | Fatal | ReactionOutcome | CC BY | 33410888 | 18,752,851 | 2021-01-07 |
What was the outcome of reaction 'Choking'? | Determination of Seven Antidepressants in Pericardial Fluid by Means of Dispersive Liquid-Liquid Microextraction (DLLME) and Gas Chromatography-Mass Spectrometry (GC/MS).
Although blood is often used to detect and quantify the presence of drugs, there are some instances where samples obtained from other biological matr... | Fatal | ReactionOutcome | CC BY | 33410888 | 18,752,851 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Opisthotonus'. | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | DEXMEDETOMIDINE, FENTANYL, HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN, MAGNESIUM SULFATE, METRONIDAZOLE, TETANUS TOXOIDS | DrugsGivenReaction | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the administration route of drug 'DEXMEDETOMIDINE'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the administration route of drug 'FENTANYL'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the administration route of drug 'HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the administration route of drug 'MAGNESIUM SULFATE'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the administration route of drug 'TETANUS TOXOIDS'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Intramuscular | DrugAdministrationRoute | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the dosage of drug 'HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | 4500 INTERNATIONAL UNIT | DrugDosageText | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the dosage of drug 'MAGNESIUM SULFATE'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | 2 GRAM, QD | DrugDosageText | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the dosage of drug 'METRONIDAZOLE'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | 500 MG, Q 8 HR | DrugDosageText | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
What was the outcome of reaction 'Opisthotonus'? | Non-surgical treatment of tetanus infection associated with breast cancer skin ulcer: a case report and literature review.
BACKGROUND
Previous studies have reported poor prognosis in cases of tetanus that develops after bacteria enters via breast cancer-related skin ulcers that are not treated with surgical debridement... | Recovered | ReactionOutcome | CC BY | 33413196 | 18,794,500 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
BACKGROUND
Although it is known that malignancies can be associated with dermatomyositis, there are few reports on dermatomyositis associated with prostate cancer with neuroendocrine differentiation.
METHODS
A 63-year-old man... | CISPLATIN, DOCETAXEL, ETOPOSIDE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33413292 | 18,769,778 | 2021-01-07 |
What was the administration route of drug 'PREDNISOLONE'? | Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
BACKGROUND
Although it is known that malignancies can be associated with dermatomyositis, there are few reports on dermatomyositis associated with prostate cancer with neuroendocrine differentiation.
METHODS
A 63-year-old man... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413292 | 18,769,778 | 2021-01-07 |
What was the dosage of drug 'CISPLATIN'? | Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
BACKGROUND
Although it is known that malignancies can be associated with dermatomyositis, there are few reports on dermatomyositis associated with prostate cancer with neuroendocrine differentiation.
METHODS
A 63-year-old man... | 20 MG/M2, EVERY 3 WEEKS | DrugDosageText | CC BY | 33413292 | 18,769,778 | 2021-01-07 |
What was the dosage of drug 'DOCETAXEL'? | Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
BACKGROUND
Although it is known that malignancies can be associated with dermatomyositis, there are few reports on dermatomyositis associated with prostate cancer with neuroendocrine differentiation.
METHODS
A 63-year-old man... | 70 MG/M2, EVERY 3 WEEKS | DrugDosageText | CC BY | 33413292 | 18,769,778 | 2021-01-07 |
What was the dosage of drug 'ETOPOSIDE'? | Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
BACKGROUND
Although it is known that malignancies can be associated with dermatomyositis, there are few reports on dermatomyositis associated with prostate cancer with neuroendocrine differentiation.
METHODS
A 63-year-old man... | 100 MG/M2, EVERY 3 WEEKS | DrugDosageText | CC BY | 33413292 | 18,769,778 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | ARTESUNATE, CEFTRIAXONE, CHLOROQUINE, NOREPINEPHRINE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
What was the administration route of drug 'ARTESUNATE'? | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
What was the administration route of drug 'CEFTRIAXONE'? | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
What was the administration route of drug 'CHLOROQUINE'? | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | Oral | DrugAdministrationRoute | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
What was the administration route of drug 'NOREPINEPHRINE'? | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.
Impaired autonomic control of postural homeostasis resulting in orthostatic hypotension has been described in falciparum malaria. However, severe orthostatic intolerance in Plasmodium vivax has been rarely reported. A case of non-immu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33413379 | 18,897,227 | 2021-01-07 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.